Saeed Motahari, President & CEO at Insys Therapeutics, Inc. (INSY), bought 5,400 shares at $11.10 ($60K) on 2017-06-14, disclosed to the SEC on 2017-06-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |